Home
>
National Drug Code (NDC)
>
Budesonide Inhalation
Budesonide Inhalation - 0591-3767-30 - (Budesonide)
Drug Information of Budesonide Inhalation
| Product NDC: | 0591-3767 |
| Proprietary Name: | Budesonide Inhalation |
| Non Proprietary Name: | Budesonide |
| Active Ingredient(s): | .25 mg/2mL & nbsp; Budesonide |
| Administration Route(s): | RESPIRATORY (INHALATION) |
| Dosage Form(s): | SUSPENSION |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Budesonide Inhalation
| Product NDC: | 0591-3767 |
| Labeler Name: | Watson Laboratories, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA078404 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20130402 |
Package Information of Budesonide Inhalation
| Package NDC: | 0591-3767-30 |
| Package Description: | 6 POUCH in 1 CARTON (0591-3767-30) > 5 VIAL in 1 POUCH > 2 mL in 1 VIAL |
NDC Information of Budesonide Inhalation
| NDC Code | 0591-3767-30 |
| Proprietary Name | Budesonide Inhalation |
| Package Description | 6 POUCH in 1 CARTON (0591-3767-30) > 5 VIAL in 1 POUCH > 2 mL in 1 VIAL |
| Product NDC | 0591-3767 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Budesonide |
| Dosage Form Name | SUSPENSION |
| Route Name | RESPIRATORY (INHALATION) |
| Start Marketing Date | 20130402 |
| Marketing Category Name | ANDA |
| Labeler Name | Watson Laboratories, Inc. |
| Substance Name | BUDESONIDE |
| Strength Number | .25 |
| Strength Unit | mg/2mL |
| Pharmaceutical Classes | Corticosteroid [EPC],Corticosteroid Hormone Receptor Agonists [MoA] |
